Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-01

Clinical Trial Update: Fetal Immunity to Falciparum Malaria

View source ↗

Summary

This clinical trial update reports a completed study investigating fetal immunity to Plasmodium falciparum malaria sponsored by NIAID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Malaria | Status: COMPLETED